Added pollen protection If grass and other pollens are making it tough for you to balance your day, 10 On Your Side Health Expert, Doctor Geoff Harter with Jefferson Surgical Clinic in Roanoke says there are a few simple ways to feel better. He says, “If you are mowing the lawn or using a weed eater particularly something that [...]
Source: feedproxy.google.comSeattle Genetics To Present SGN-35 And Lintuzumab Clinical Data At The European Hematology Association Congress Seattle Genetics, Inc. (Nasdaq:SGEN) announced that data from a phase I clinical trial evaluating every three week dosing of SGN-35 and a phase I clinical trial of lintuzumab (SGN-33) will be reported at the 14th Congress of the European Hematology Association (EHA) being held June 4-7, 2009 in Berlin, Germany. The abstracts are available from the EHA website at http://www.ehaweb.org.
Source: www.medicalnewstoday.comCombination therapy may prevent stroke For people with atrial fibrillation who face an increased risk of stroke, Coumadin (warfarin) is considered standard treatment. But for those who cannot or will not take the drug, might aspirin along with a different clot-busting drug offer protection? A study in the March 31 online issue of the New England Journal of Medicine involved 7,554 [...]
Source: feedproxy.google.comBayer To Present Data On Development Compound BAY 73-4506 At 45th Annual Meeting Of The American Society Of Clinical Oncology Bayer HealthCare Pharmaceuticals, Inc. announced that new data on Bayer's novel anti-cancer development candidate BAY 73-4506 (DAST-Inhibitor) will be presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, May 29 - June 2.
Source: www.medicalnewstoday.comSleeping Through Dialysis: No Nightmare For Kidney Patients Dialysis takes hours of kidney disease patients' time several days a week, so why not do it at night while sleeping? Overnight dialysis is more convenient for some patients and offers significant benefits over shorter daytime treatments, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Source: www.medicalnewstoday.comNew Stem Cell Research Unlocks Unknown Therapies "Stem cell research and regenerative medicine are in an extremely exciting phase right now. We are gaining knowledge very fast and many companies are being formed and are starting clinical trials in different areas," says Dr Jonas Frisén. As an example, a first-in-human study was just initiated for Parkinson's disease patients with the drug product, sNN0031, from the Swedish company NeuroNova.
Source: www.medicalnewstoday.com
# posted by Network @ 8:59 PM
